Cancel
Melodie Domurad
VP, Clinical and Regulatory Affairs
@
Day Zero Diagnostics
p4kkx9f@vx91v9v6b7kq77x6q0.pb6
Sign up to see email
Known information
- Has over 25 years of experience in the development, design, and implementation of phase I-IV clinical trials of IVDs and therapeutic devices
- Architect of multiple successful regulatory submissions to the FDA and international authorities, including IDE, 510(k), de novo, PMA and CE
- Holds a BA from Cornell University
- Earned a PhD from the University of Cincinnati
About Day Zero Diagnostics
Day Zero Diagnostics is a biotechnology company specializing in rapid, whole genome sequencing-based diagnostics for infectious diseases, with a focus on modernizing diagnosis and treatment.
Report inaccurate information
